|
News is collected from the following on-line sources: The New York Times,
American Cancer Society, MSNBC, CNN, Centerwatch, CancerNetwork, The
Washington Post, pharmalicensing.com, Medscape, NIH, and NCI.
News
12/23/02 - Biocompatibles says U.S. FDA clears tumour device
12/20/02 - Gleevec(TM) Gains FDA Approval for First-Line Treatment of Chronic
Myeloid
Leukemia (CML)
12/20/02 - Breast Cancer Cases Rising Fast in UK
12/18/02 - New cervical cancer screening guidelines issued
12/17/02 - Potential Early Biomarkers of Ovarian Cancer Identified
12/17/02 - Integrated Approach Needed for Informed Consent Process in Clinical Trials
12/17/02 - Schering's Novel HRT Product Angeliq(R) Receives First Approval in
Europe
12/13/02 - Eli Lilly seeks EU approval for Gemzar
12/10/02 - Cervical Cancer Rates Higher For
Hispanic Women
12/09/02 - Roche's NeoRecormon gains wider EU approval
12/05/02 - After Stopping Oral Contraceptives, Protection Against Ovarian Cancer
Persists
11/29/02 - Human Papillomavirus Load Tied to Outcome in Tonsillar Cancer
11/27/02 - Dose-Dense Cisplatin Plus Paclitaxel Effective in Advanced Ovarian
Cancer
11/22/02 - A Controlled Trial of a Human Papillomavirus Type 16
Vaccine
11/22/02 - Cancer Researchers Warn EU Red Tape Could Hamper Studies
11/21/02 - Anti-Cancer Compound Sensitizes Ovarian Tumors to Cisplatin
11/21/02 - Vaccine May Be First for Cancer
11/19/02 - Survey Highlights Gaps in UK Cancer Funding
11/19/02 - European Commission Approves SOMAVERT(R) for the Treatment of Acromegaly
First in a New Class of Medicines Treats Debilitating Hormone Disease
11/18/02 - Society of Gynecologic Oncologists Endorses American Cancer Society's New
Guidelines Significant Step in Cervical Cancer Screening
11/04/02 - Cerylid forms drug discovery partnership
10/29/02 - Elevated IGF-1 Linked to Risk of Ovarian Cancer in Younger Women
10/28/02 - Elbit Medical Imaging Ltd. Receives European Regulatory Approval for
Uterine Fibroid Treatments
10/28/02 - SuperGen Affiliate Files for European Approval of Paclitaxel
10/24/02 - News from the 27th Congress of the European Society for Medical
Oncology (October 18-22, 2002, Nice, France)
8/28/02 - Early Breast Cancer Increases Ovarian Cancer Risk
8/27/02 - Amgen Receives European
Commission Approval For Both Aranesp® and Neulasta™ in Oncology
|
